APPLICATION
ANDA200563
TYPE
ANDA
ORIGINAL APPROVAL
2014-03-05
LATEST ACTION
2015-10-14
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
CIPROFLOXACINPrescription
CIPROFLOXACIN 500MG/5ML · FOR SUSPENSION · ORAL
CIPROFLOXACINPrescription
CIPROFLOXACIN 250MG/5ML · FOR SUSPENSION · ORAL
Approval history
2015-10-14Labeling · Supplement 2 · standardAP
2015-02-06Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.